Advertisement msagar, Author at Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More

All articles by  

Mylan, Pfizer announce Viatris as new company name

Deriving its name from Latin, Viatris embodies the new company’s goal of providing a path—“VIA”—to three—“TRIS”—core goals: expanding access to medicines, leading by innovating to meet patient needs,

ESSA Pharma to acquire Realm Therapeutics

The acquisition, subject inter alia to Realm Shareholder approval, is intended to be implemented by means of a UK Court-sanctioned scheme of arrangement under Part 26 of the